Panelists discuss how data from Mansour and colleagues suggesting potential Bruton tyrosine kinase (BTK) inhibitor ...

Panelists discuss how successful transitions between Bruton tyrosine kinase (BTK) inhibitors require careful management of ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.

3-butanedione to achieve the same inhibitory effect. After 48 h of incubation at 28°C, the lowest concentration of 2,3-butanedione conferring complete inhibition of LB1 was 4.5 μl per plate (MIC).

Objectives: This study investigates the impact of xanthine oxidase inhibitors (XOI) on mortality in patients with cardiovascular diseases ... To analyze the factors associated with mortality, a ...

Key opinion leaders explores the management of gastrointestinal side effects in patients on osimertinib, focusing on ...

Key opinion leaders discusses strategies for handling gastrointestinal side effects in patients taking osimertinib, including ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

We read with interest the article by Marie Lund and colleagues published in The Lancet Oncology investigating the association ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...